Researchers Identify How to Destroy Cells That Cause Aging

Researchers at Ben-Gurion University of the Negev in Israel have discovered a way to destroy harmful “senescent” cells that accumulate with age and increase the kind of tissue damage and inflammation that slowly causes life to end.

University of Toledo Receives NIH Funds for Fungal Infection Research

A University of Toledo immunologist has received a federal grant to study how a type of cell unexpectedly discovered in the oral cavity helps the body fight off fungal infections.

Study Finds No Connection Between Antibiotic Use and Autoimmune Disease in Children

A groundbreaking retrospective cohort analysis of more than four million children conducted at Sungkyunkwan University in South Korea offers compelling evidence that there is no significant association between early antibiotic exposure and heightened risk of autoimmune diseases in children.

Study Finds Lymphoma Accelerates Aging of Immune Cells and Tissues

A new study reveals lymphoma can accelerate the biological aging of the immune system and other tissues.

New Vaccine Shows Promise Against Pancreatic Cancer

Early clinical and preclinical results are showing that an experimental mRNA and nanoparticle vaccine produced measurable immune responses against pancreatic cancer, and that in small patient groups, those immune responses correlated with delayed recurrence or prolonged survival.

Argenx Is Conducting a Phase IV Study to Assess Efgartigimod Ph20 SC to Treat Adult CIDP Patients

Argenx is conducting a Phase IV clinical study to evaluate how adults with chronic inflammatory demyelinating polyneuropathy transition from intravenous immune globulin treatment to efgartigimod PH20 SC.

Personalized Melanoma Vaccine Elicits Strong Immune Response

Results of a Dana-Farber Cancer Institute-initiated Phase I clinical trial for patients with melanoma show that an updated formula and delivery of the NeoVax personalized cancer vaccine called NeoVaxMI is safe, feasible and improves the vaccine-specific immune response compared to previous trials of the platform.

University of Toledo Awarded Funds to Explore Immune Response to Oral Thrush

The University of Toledo will receive $473,632 from the National Institute of Dental and Craniofacial Research to explore how the body’s immune system responds to the condition known as oral thrush.

Activating B Cells Key to TIL Cancer Therapy Effectiveness

Researchers at Moffitt Cancer Center have found that tapping into the body’s own immune system and activating a type of immune cell known as B cells could be the key to boosting the effectiveness of tumor-infiltrating lymphocyte, or TIL therapy.

Nasal Spray Blocks Infuenza in Mice

Scientists at Ohio State University have created an antibody that was successful in protecting a majority of the tested mice from lethal influenza (flu) doses, even preventing some from experiencing any symptoms at all.